Jonathan G. Zaroff

Jonathan G. Zaroff

Auto-generated profile, based on publicly available information

Jonathan G. Zaroff

Division of Research, Kaiser Permanente Northern California, Oakland

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2009 in Current Neurology and Neuroscience Reports
Verified
Journal Article
Closed access
PDF file
HNHoang Nguyen
Hoang Nguyen
JZJonathan G. Zaroff
Jonathan G. Zaroff

1 February 2009 in Stroke
Verified
Journal Article
Closed access
PDF file
LCLandis A. Coghlan
Landis A. Coghlan
BHBradley J. Hindman
Bradley J. Hindman
EBEmine O. Bayman
Emine O. Bayman
NBNader M. Banki
Nader M. Banki
AGAdrian W. Gelb
Adrian W. Gelb
IIIHAST Investigators
IHAST Investigators
Background and Purpose— Electrocardiographic abnormalities are common after subarachnoid hemorrhage, but their significance remains uncertain. The aim of this study was to determine whether any specific electrocardiographic abnormalities are independently associated with adverse neurological outcomes. Methods— This was a substudy of the Intraoperative Hypothermia Aneurysm Surgery Trial, which was designed to determine whether intraoperative hypothermia would improve neurological outcome in patients with subarachnoid hemorrhage undergoing aneurysm surgery. The outcome was the 3-month Glasgow Outcome Score treated as both a categorical measure (Glasgow Outcome Score 1 [good outcome] to 5 [death]) and dichotomously (mortality/Glasgow Outcome Score 5 versus Glasgow Outcome Score 1 to 4). The predictor variables were preoperative electrocardiographic characteristics, including heart rate, corrected QT interval, and ST- and T-wave abnormalities. Univariate logistic regression was performed to screen for significant electrocardiographic variables, which were then tested for associations with the outcome by multivariate logistic regression adjusting for clinical covariates. Results— The study included 588 patients, of whom 31 (5%) died. There was a significant, nonlinear association between heart rate and mortality such that lowest quartile (≤60 beats/min; OR, 6.5; P =0.027) and highest quartile (>80 beats/min; OR, 8.8; P =0.006) were associated with higher risk. There was also a significant association between nonspecific ST- and T-wave abnormalities and mortality (OR, 3.1; P =0.031). Conclusions— Bradycardia, relative tachycardia, and nonspecific ST- and T-wave abnormalities are strongly and independently associated with 3-month mortality after subarachnoid hemorrhage. Further research should be performed to determine whether there is a causal relationship between cardiac dysfunction and neurological outcome after subarachnoid hemorrhage.

1 June 2020 in JAMA Network Open
Verified
Journal Article
Closed access
PDF file
JZJonathan G. Zaroff
Jonathan G. Zaroff
TCT. Craig Cheetham
T. Craig Cheetham
NPNiki Palmetto
Niki Palmetto
LALucy Almers
Lucy Almers
CQCharles Quesenberry
Charles Quesenberry
DCDouglas A. Corley
Douglas A. Corley
Azithromycin, a macrolide, is one of the most commonly prescribed antibiotics in the US, with an estimated 44.9 million prescriptions dispensed to outpatients in 2016.1 A safety concern was raised following a study by Ray et al in 20122 that reported an association of azithromycin use with sudden cardiac death. Prompted by concern over QT prolongation and reports of cardiac deaths, the US Food and Drug Administration made changes to the product labeling between 2011 and 2013 advising against using azithromycin in patients with known risk factors for ventricular arrhythmia.3

16 July 2013 in Pharmacoepidemiology and Drug Safety
Verified
Journal Article
Closed access
PDF file
CICarlos Iribarren
Carlos Iribarren
ARAlfred D. Round
Alfred D. Round
JPJonathan A. Peng
Jonathan A. Peng
MLMeng Lu
Meng Lu
JZJonathan G. Zaroff
Jonathan G. Zaroff
PSPaul Stang
Paul Stang

19 July 2011 in Neurocritical Care
Verified
Journal Article
Closed access
PDF file
JZJonathan G. Zaroff
Jonathan G. Zaroff
JLJonathan Leong
Jonathan Leong
HKHelen Kim
Helen Kim
WYWilliam L. Young
William L. Young
SCSean P. Cullen
Sean P. Cullen
SSSteve Sidney
Steve Sidney

1 December 2003 in Current Treatment Options in Cardiovascular Medicine
Verified
Journal Article
Closed access
PDF file
NBNader M. Banki
Nader M. Banki
JZJonathan G. Zaroff
Jonathan G. Zaroff